BioVie Presents Data for NE3107 at 2023 International Congress of Parkinson's Disease and Movement Disorders Seite 1

28.08.2023 - New preclinical data characterizing NE3107 mechanism of action featured in oral presentationPhamacokinetic data from Phase 2a study supports potential co-administration of NE3107 with carbidopa/levodopaSeparate analysis of Phase 2a study data shows ... Seite 1

Related Keywords

Copenhagen ,Køavn ,Denmark ,Clarence Ahlem ,Movement Disorders ,Biovie Inc ,Nasdaq ,International Congress ,Vie Inc ,Denmark August ,Inflammatory Treatment ,Motor Activity ,Neurodegenerative Features ,Marmoset Monkey Model ,Christopherl Reading ,Biovie Registereda Chart ,Iovie Registereda Kurs ,Iovie Registereda Aktie ,